Tech Company Financing Transactions
Juno Therapeutics Funding Round
Bezos Expeditions and Venrock participated in a $25 million Series A funding round for Juno Therapeutics. This venture round was announced on 1/13/2014.
Transaction Overview
Company Name
Announced On
1/13/2014
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series A
Investors
Venrock (Anthony Evnin)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
307 Westlake Avenue North 300
Seattle, WA 98109
USA
Seattle, WA 98109
USA
Phone
Website
Email Address
Overview
Juno is a clinical-stage company that brings together three of the world's leading cancer centers -- Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and Seattle Children's Research Institute -- in unique partnership to advance a broad pipeline of breakthrough immunotherapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Hans Bishop
Chief Financial Officer
Steve Harr
Chief Medical Officer
Mark Gilbert
Chief Scientific Officer
Ken Mohler
VP - General Counsel
Barney Cassidy
VP - Human Resources
Robin Andrulevich
VP - Manufacturing
Andy Walker
VP - R & D
Mark Frohlich
VP - Regulatory Affairs
Elizabeth Smith
Browse more venture capital transactions:
Prev: 1/13/2014: Kontagent venture capital transaction
Next: 1/13/2014: onFocus Healthcare venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs